ALEXANDRIA, Va., July 23 -- United States Patent no. 12,364,666, issued on July 22, was assigned to Societe des Produits Nestle S.A. (Vevey, Switzerland).
"Stable low digestive enzyme content formulation" was invented by Giovanni Ortenzi (Monza, Italy), Giuseppe De Franza (Milan), Danilo Clementi (Seriate, Italy), Christian Stollberg (Carugate, Italy) and Luigi Boltri (Agrate Brianza, Italy).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is directed to a pharmaceutical composition or dosage form having a stable, low (diluted) digestive enzyme content comprising at least one digestive enzyme and at least one carrier, or a dosage form thereof. The invention is also directed to a process of...